10 likes | 97 Views
Explore the significance of IgVH mutational status in chronic lymphocytic leukemia (CLL) patients for risk stratification and treatment decisions. Learn about the impact of low, intermediate, and high-risk categories on disease progression and outcomes.
E N D
IgVH unmutated IgVH mutated Low-risk Intermediate-risk High-risk P14 cluster N6 cluster ZAP-70 CD38 IgVH status Supplementary Figure 1